dmso bpc 157 BP-157 oral Liposomal *** This item can not be returned/refunded due to refrigerating needs*** BPC-157 (10mg) – Alpha BioMed

It is the only growth hormone-releasing peptide with FDA approval

The peptide's ability to activate VEGFR2-nitric oxide signaling in bone tissue enhances bone matrix deposition and fracture consolidation

Short synthetic peptides can be designed to target these signaling systems with a level of precision that conventional drugs often cannot achieve, making them scientifically interesting candidates for hair biology research

Archived from the original on December 11, 2020

Patients on a 5-ASA or immunomodulator at baseline maintained stable doses throughout the study *Includes 2 patients who enrolled in the trial but never received any study drug